ORAMED PHARMACEUTICALS INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ORAMED PHARMACEUTICALS INC. has filed 932 SEC EDGAR filings since 29 Nov 2002

SEC filing history

Showing 401-425 of 773 matching filings.

Per page
25
Current page
17
UPLOAD

UPLOAD filing

Filing date
28 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14A File 001-35813

PRELIMINARY REVISED PROXY SOLICITING MATERIALS

Filing date
28 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
21 Jul 2017
Reporting date
18 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-35813

PRELIMINARY PROXY STATEMENT

Filing date
20 Jul 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
06 Jul 2017
Reporting date
31 May 2017
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Jul 2017
Reporting date
30 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

8-K

Filing date
08 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
19 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
19 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

8-K

Filing date
10 Apr 2017
Reporting date
10 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-215525

424B5

Filing date
05 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
21 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
21 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
03 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Mar 2017
Reporting date
09 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Mar 2017
Reporting date
09 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .